ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Other Agencies Offer Advice; No Money For Oncology Nurse Training

February 24, 1978

Research Integrity: Collins’ Student Falsified Data, ORI Finds

August 22, 1997

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005